Autoinhibitory mechanisms in receptor tyrosine kinases

被引:44
作者
Hubbard, SR
机构
[1] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA
关键词
receptor tyrosine kinase; autoinhibition; tyrosine phosphorylation; signal transduction; growth factor receptor; review;
D O I
10.2741/hubbard
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Receptor tyrosine kinases (RTKs) are single-pass transmembrane receptors that possess intrinsic tyrosine kinase catalytic activity in their cytoplasmic domains. RTKs are critical components in signal transduction pathways involved in cellular proliferation, differentiation, migration, and metabolism. This large protein family includes the receptors for many growth factors and for insulin. Ligand binding to the extracellular portion of these receptors results in receptor dimerization, which facilitates trans-autophosphorylation of specific tyrosine residues in the cytoplasmic portion. The phosphotyrosine residues enhance receptor catalytic activity and/or provide docking sites for downstream signaling proteins. Because of the critical roles played by RTKs in cellular signaling processes, their catalytic activity is normally under tight control by intrinsic regulatory mechanisms as well as by protein tyrosine phosphatases. This review will focus on the autoinhibitory mechanisms that modulate RTK catalytic activity.
引用
收藏
页码:D330 / D340
页数:11
相关论文
共 74 条
[1]   Activation of the insulin receptor's kinase domain changes the rate-determining step of substrate phosphorylation [J].
Ablooglu, AJ ;
Kohanski, RA .
BIOCHEMISTRY, 2001, 40 (02) :504-513
[2]   APS, an adapter protein with a PH and SH2 domain, is a substrate for the insulin receptor kinase [J].
Ahmed, Z ;
Smith, BJ ;
Kotani, K ;
Wilden, P ;
Pillay, TS .
BIOCHEMICAL JOURNAL, 1999, 341 :665-668
[3]   Full activation of the platelet-derived growth factor β-receptor kinase involves multiple events [J].
Baxter, RM ;
Secrist, JP ;
Vaillancourt, RR ;
Kazlauskas, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) :17050-17055
[4]   A RECURRENT MUTATION IN THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH-FACTOR RECEPTOR-3 CAUSES HYPOCHONDROPLASIA [J].
BELLUS, GA ;
MCINTOSH, I ;
SMITH, EA ;
AYLSWORTH, AS ;
KAITILA, I ;
HORTON, WA ;
GREENHAW, GA ;
HECHT, JT ;
FRANCOMANO, CA .
NATURE GENETICS, 1995, 10 (03) :357-359
[5]   Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of eph receptors [J].
Binns, KL ;
Taylor, PP ;
Sicheri, F ;
Pawson, T ;
Holland, SJ .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (13) :4791-4805
[6]   Oncogenic kinase signalling [J].
Blume-Jensen, P ;
Hunter, T .
NATURE, 2001, 411 (6835) :355-365
[7]   The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck [J].
Bocciardi, R ;
Mograbi, B ;
Pasini, B ;
Borrello, MG ;
Pierotti, MA ;
Bourget, I ;
Fischer, S ;
Romeo, G ;
Rossi, B .
ONCOGENE, 1997, 15 (19) :2257-2265
[8]   Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain [J].
Constantinescu, SN ;
Keren, T ;
Socolovsky, M ;
Nam, HS ;
Henis, YI ;
Lodish, HF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (08) :4379-4384
[9]  
Cunningham ME, 1997, J BIOL CHEM, V272, P10957
[10]   Skeletal disorders associated with fibroblast growth factor receptor mutations [J].
DeMoerlooze, L ;
Dickson, C .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1997, 7 (03) :378-385